RAPIVAB
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for RAPIVAB, covering 2011-11-11 to 2024-06-13. Get the full timeline:
Most recent: FDA Approved: RAPIVAB — Supplemental Application (BioCryst Pharmaceuticals, Inc.)